ArticleFrontiers in pharmacology2021

Network Meta-Analysis on the Effects of SGLT2 Inhibitors Versus Finerenone on Cardiorenal Outcomes in Patients With Type 2 Diabetes and Chronic Kidney Disease.

Li-Min Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.